Metabolic syndrome and its components as predictors of stroke in middle-aged and elderly Chinese people

Neurological Research

Volumn 33, Issue 5, 2011, Pages 453-459

  Jia, Zhaoxia ^a   Wu, Shouling ^b   Zhou, Yong ^c   Wang, Wenjuan ^c   Liu, Xiurong ^b   Wang, Liye ^b   Wang, Yilong ^c   Wang, Yongjun ^c   Liang, Wannian ^a,d   Zhao, Xingquan ^c   Zhang, Yaqing ^c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NORTH CHINA COAL MEDICAL COLLEGE   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d BEIJING HOSPITAL   (China)

Author keywords

Metabolic syndrome; Prospective study; Risk factor; Stroke

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CHINESE; DIABETES MELLITUS; FEMALE; GENDER; HEART INFARCTION; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; STROKE; WAIST CIRCUMFERENCE;

ADULT; AGED; AGED, 80 AND OVER; AGING; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COMORBIDITY; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROSPECTIVE STUDIES; STROKE;

EID: 79958744484     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164111X13007856083882     Document Type: Article

References (35)

1. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 2008;336(7659):1475-82.
2. Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR. Creactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation 2008;118(22):2243-51.
3. Hadjiev DI, Mineva PP, Vukov MI. Multiple modifiable risk factors for first ischemic stroke: a population-based epidemiological study. Eur J Neurol 2003;10(5):577-82.
4. D'Agostino RB, Wolf PA, Belanger AJ, Kannel WB. Stroke risk profile: adjustment for antihypertensive medication: the Framingham study. Stroke 1994;25(1):40-3.
5. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288(21):2709-16.
6. Onat A, Ceyhan K, Basar O, Erer B, Toprak S, Sansoy V. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels-a prospective and cross-sectional evaluation. Atherosclerosis 2002;165(2):285-92.
7. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, et al. The metabolic syndrome and 11- year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 2005;28(2):385-90.
8. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37(12):1595-607.
9. WHO: Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Geneva: World Health Organization; 1999.
10. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 2005;366(9491):1059-62.
11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285(19):2486-97.
12. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112(17):2735-52.
13. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999;16(5):442-3.
14. Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003;9(3):237-52.
15. Wang C, Hou XH, Bao YQ, Pan J, Zuo Y, Zhong W, et al. The metabolic syndrome increased risk of cardiovascular events in Chinese-A community based study. Int J Cardiol 2010;139: 159-65.
16. Chen XY, Thomas GN, Chen YK, Chan JC, Wong KS. Atherosclerotic vascular disease rather than metabolic syndrome predicts ischemic stroke in diabetic patients. Cerebrovasc Dis 2010;30:374-9.
17. Zhang WW, Liu CY, Wang YJ, Xu ZQ, Chen Y, Zhou HD. Metabolic syndrome increases the risk of stroke: a 5-year follow-up study in a Chinese population. J Neurol 2009;256: 1493-9.
18. Kahn R, Buse J, Ferrannini E, Stern M, American Diabetes Association, European Association for the Study of Diabetes. The metabolic syndrome: time for a critical appraisal: jointstatement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005;28(9):2289-304.
19. Sattar N, McConnachie A, Shaper AG, Blauw GJ, Buckley BM, de Craen AJ, et al. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? outcome data from two prospective studies. Lancet 2008;371(9628):1927-35.
20. Wang J, Ruotsalainen S, Moilanen L, Lepistö P, Laakso M, Kuusisto J. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns. Eur Heart J 2007;28(7):857-64.
21. Mozaffarian D, Kamineni A, Prineas RJ, Siscovick DS. Metabolic syndrome and mortality in older adults: the cardiovascular health study. Arch Intern Med 2008;168(9):969-78.
22. Welborn TA, Dhaliwal SS. Preferred clinical measures of central obesity for predicting mortality. Eur J Clin Nutr 2007;61(12):1373-9.
23. Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ 1980;58:113-30.
24. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systermatic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007;49(4):403-14.
25. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003;108(4):414-9
26. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation 2003;107(3):391-7.
27. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson PW. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the framingham offspring study. Circulation 2004;110(4):380-5.
28. Chen HJ, Bai CH, Yeh WT, Chiu HC, Pan WH. Influence of metabolic syndrome and general obesity on the risk of ischemic stroke. Stroke 2006;37(4):1060-4.
29. Ninomiya JK, L'Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 2004;109(1):42-6.
30. Dekker JM, Girman C, Rhodes T, Nijpels G, Stehouwer CD, Bouter LM, et al. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation 2005;112(5): 666-73.
31. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP, San Antonio Heart Study. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 2004;110(10):1251-7.
32. Chen PC, Chien KL, Hsu HC, Su TC, Sung FC, Lee YT. Metabolic syndrome and C-reactive protein in stroke prediction: a prospective study in Taiwan. Metabolism 2009;58(6): 772-8.
33. Young-Ho K, Sung-Il C, Hye-Ryun K. Risks for cardiovascular disease, stroke, ischaemic heart disease, and diabetes mellitus associated with the metabolic syndrome using the new harmonized definition: Findings from nationally representative longitudinal data from an Asian population.Atherosclerosis 2010;doi:10.1016/j.atherosclerosis.2010.09.009
34. Deurenberg P, Deurenberg-Yap M, Guricci S. Asians are different from Caucasians and from each other in their body mass index/body fat percent relationship. Obes Rev 2002;3(3): 141-6.
35. Wang W, Luo YX, Liu YN, Cui C, Wu L, Wang Y, et al. Prevalence of metabolic syndrome and optimal waist circumference cut-off points for adults in Beijing. Diabetes Res Clin Pract 2010;88(2):209-16.